GE HealthCare CPO receives stock and option awards

GE HealthCare Technologies Inc. Chief People Officer Adam Y. Holton reported awards of company equity on March 2, 2026.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. Chief People Officer Adam Y. Holton reported awards of company equity on March 2, 2026. He received an employee stock option for 14,348 shares of common stock at an exercise price of $0.00 per share, bringing his directly held options to 14,348.

On the same date, he was granted 5,457 shares of common stock, increasing his directly held common shares to 22,225. The common stock award consists of restricted stock units, with 33% vesting on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029. The stock options follow the same 33%/33%/34% vesting and exercisability schedule on those dates.

Insider Trade Summary

Grant/Award: 19,805 shares

Grant/Award 2 txns

Insider Holton Adam Y

Role Chief People Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	14,348	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	5,457	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 14,348 contracts (Direct); Common Stock, par value $0.01 per share — 22,225 shares (Direct)

Footnotes (3)

F1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.
F2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
F3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did GEHC Chief People Officer Adam Holton report in this Form 4?

Adam Holton reported equity awards in GE HealthCare stock and options. He received 14,348 employee stock options and 5,457 shares of common stock as part of his compensation, all held directly in his name.

How many GEHC stock options were granted to Adam Holton?

He was granted 14,348 employee stock options on March 2, 2026. These options give him the right to buy GE HealthCare common stock, with vesting and exercisability occurring in three annual tranches through September 2, 2029.

How many GE HealthCare common shares does Adam Holton own after this filing?

After the reported award, Adam Holton directly holds 22,225 shares of GE HealthCare common stock. This total includes the 5,457 new shares granted as restricted stock units on March 2, 2026, subject to future vesting dates.

What is the vesting schedule for Adam Holton’s GEHC restricted stock units?

The restricted stock units vest over three years. Thirty-three percent vest on September 2, 2027, another 33% on September 2, 2028, and the remaining 34% on September 2, 2029, aligning with a typical long-term incentive structure.

When do Adam Holton’s GEHC stock options become exercisable?

The stock options become exercisable in three stages. Thirty-three percent become exercisable on September 2, 2027, another 33% on September 2, 2028, and the final 34% on September 2, 2029, matching the restricted stock unit vesting pattern.

Were Adam Holton’s GEHC equity awards reported as purchases or grants?

They were reported as grants, not open-market purchases. The Form 4 uses transaction code “A” for grant or award, indicating the equity was awarded as compensation at a stated price of $0.00 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/04/2026 - 04:25 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Holton Adam Y

(Last)

(First)

(Middle)

500 W. MONROE STREET

(Street)

CHICAGO

60661

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	03/02/2026		A		5,457⁽¹⁾⁽²⁾	A	$0	22,225	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$80.16	03/02/2026		A		14,348		⁽³⁾	03/02/2036	Common Stock, par value $0.01 per share	14,348	$0⁽³⁾	14,348	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR